findmyKOL
Clinical trialNCT05707832CompletedPhase 3Interventional

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

SponsorCSPC Ouyi Pharmaceutical Co., Ltd.Enrollment31Invasive AspergillosisInvasive Candidiasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Baodong Ye

    The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

    Principal Investigator
  • Fang Zhou

    Chinese the 960th Hospital of the Joint Logistics Support Department of the People's Liberation Army

    Principal Investigator
  • Fenge Yang

    Union Hospital, Affiliated to Fujian Medical University

    Principal Investigator
  • Jinhai Ren

    The Second Hospital of Hebei Medical University

    Principal Investigator
  • Jishi Wang

    The Affiliated Hospital Of Guizhou Medical University

    Principal Investigator
  • Lina Zhang

    Henan Provincial People's Hospital

    Principal Investigator
  • Mei Hong

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Principal Investigator
  • Ming H

    Qilu Hospital of Shandong University

    Principal Investigator
  • Ming Jiang

    First Affiliated Hospital of Xinjiang Medical University

    Principal Investigator
  • Sizhou Feng

    Chinese Academy of Medical Sciences

    Principal Investigator
  • Suning Chen

    The First Affiliated Hospital of Soochow University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Mar 2023
Primary completion
30 Jul 2024
Completion
31 Mar 2025
Last update posted
9 Apr 2025
Registered enrollment
31
Registry id
NCT05707832

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.